1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathino

Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathino

  1. Anonymous
    Forensic Science International 197 (2010) 59–66
    Andrew Camilleri, Martin R. Johnston, Michael Brennan, Sean Davis, David G.E. Caldicott

    In August 2007, four capsules containing white powders, said to have originated from an Israel-based
    Internet company ‘‘Neorganics’’, were anonymously delivered to the Royal Adelaide Hospital, South
    Australia. The capsules were analysed and the active components were identified including 4-
    methylmethcathinone, 2-fluoromethamphetamine, a-phthalimidopropiophenone and N-ethylcathinone,
    all of which were unlisted within South Australian controlled substance regulations. We examined
    the relevant scientific literature surrounding these chemicals and present both GCMS and NMR data for
    4-methylmethcathinone and a-phthalimidopropiophenone, which have previously received little
    attention. We also present the vapour- and condensed-phase infrared spectra (IR) of 4-methylmethcathinone
    as these have also not been reported in the literature previously. We discuss the issues
    surrounding whether these chemicals can be classified as controlled substance analogues and the likely
    impact this could have on prosecutions of individuals distributing these products.